Oral Wegovy Launches in the US: A New Era for GLP-1 Peptide Therapy
The FDA has approved the first oral GLP-1 medication for weight loss, and Novo Nordisk's Wegovy pill is now available at US pharmacies. This breakthrough in peptide delivery technology could fundamentally change how millions access obesity treatment.